v3.20.1
Additional paid in capital (Tables)
3 Months Ended
Mar. 31, 2020
Stockholders' Equity Note [Abstract]  
Schedule of Share-based Compensation, Stock Options, Activity

     
  Three Months Ended Year Ended
  March 31, 2020 December 31, 2019
    Weighted Average   Weighted Average
  Number of Options

Exercise

Price

Number of

Options

Exercise

Price

Outstanding, beginning of period 5,236,401,500 $ 0.003 5,014,851,500 $ 0.002
Granted - $ - 254,050,000 $ 0.028
Exercised - $ - (26,000,000) $ (0.003)
Cancelled (3,500,000) $ (0.032) (6,500,000) $ (0.015)
Outstanding, end of period 5,232,901,500 $ 0.003 5,236,401,500 $ 0.003
             
Exercisable, end of period 5,151,901,500 $ 0.003 5,154,901,500 $ 0.003

 

Schedule of Options Outstanding

 

    March 31, 2020   December 31, 2019
Expiry Date   Options Exercise Price Intrinsic Value   Options Exercise Price Intrinsic Value
                         
May 30, 2020   10,000,000 $ 0.035 $ 0.004   10,000,000 $ 0.035 $ -
July 1, 2021   4,365,001,300 $ 0.002 $ 0.037   4,365,001,300 $ 0.002 $ 0.015
November 27, 2022   6,950,000 $ 0.015 $ 0.024   7,200,000 $ 0.015 $ 0.002
January 31, 2023   40,500,000 $ 0.015 $ 0.024   40,500,000 $ 0.015 $ 0.002
June 13, 2023   5,000,000 $ 0.015 $ 0.024   5,000,000 $ 0.015 $ 0.002
October 1, 2023   300,000 $ 0.050 $ -   300,000 $ 0.050 $ -
February 3, 2024   10,000,000 $ 0.035 $ 0.004   10,000,000 $ 0.035 $ -
March 14, 2024   9,150,000 $ 0.035 $ 0.004   9,150,000 $ 0.035 $ -
April 12, 2024   560,000,200 $ 0.002 $ 0.037   560,000,200 $ 0.002 $ 0.015
April 12, 2024   3,900,000 $ 0.015 $ 0.024   4,150,000 $ 0.015 $ 0.002
April 12, 2024   200,000 $ 0.030 $ 0.009   200,000 $ 0.030 $ -
May 6, 2024   13,000,000 $ 0.035 $ 0.004   13,000,000 $ 0.035 $ -
May 17, 2024   40,000,000 $ 0.050 $ -   40,000,000 $ 0.050 $ -
May 17, 2024   24,900,000 $ 0.035 $ 0.004   27,900,000 $ 0.035 $ -
June 17, 2024   5,000,000 $ 0.050 $ -   5,000,000 $ 0.050 $ -
June 17, 2024   5,000,000 $ 0.035 $ 0.004   5,000,000 $ 0.035 $ -
August 16, 2024   2,500,000 $ 0.050 $ -   2,500,000 $ 0.050 $ -
September 6, 2024   1,000,000 $ 0.050 $ -   1,000,000 $ 0.050 $ -
September 17, 2024   5,000,000 $ 0.035 $ 0.004   5,000,000 $ 0.035 $ -
October 3, 2024   3,500,000 $ 0.035 $ 0.004   3,500,000 $ 0.035 $ -
October 24, 2024   2,000,000 $ 0.035 $ 0.004   2,000,000 $ 0.035 $ -
December 11, 2024   120,000,000 $ 0.015 $ 0.024   120,000,000 $ 0.015 $ 0.002
Total   5,232,901,500 $ 0.003 $ 0.036   5,236,401,500 $ 0.003 $ 0.014

Weighted Average Remaining

Contractual Life

  1.71           1.96      
                                   
Schedule of Fair Value of Stock Options Granted-Allocation

 

       
   Three Months
Ended March 31, 2020
  Three Months
Ended March 31, 2019
       
General, selling and administration expenses:  $—     $264,656 
Product development expense   79    337 
Professional expense   —      199,192 
           
   $79   $464,185 

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

 

   March 31,
2020
  December 31,
2019
       
Risk-free interest rate   N/A    1.84%
Expected life   N/A    5 years 
Expected dividends   N/A    0%
Expected volatility   N/A    306%
Forfeiture rate   N/A    0%